CGA and neoplasm: The fact that many of the non-primary endpoint responders in our study were nevertheless observed to have an objective tumor response and the majority of patients had a reduction in requirements for antihypertensive medications that lasted less than 6 months, the CgA biomarker may well have captured this non-primary endpoint biochemical response.